Adenoviral Pneumonia During Etanercept Treatment in a Patient with Rheumatoid Arthritis
Min-Jung Kang, Myung-Sin Kim, Eun-Hwa Choi, Kyoung-Eun Lee, You-Kyoung Kim, Hee-Jung Choi
Korean J Intern Med. 2007;22(1):63-66. Published online March 31, 2007
Inhibitors of tumor necrosis factor-alpha (TNF-α) have been approved for treating rheumatoid arthritis. As one of the biological response modifiers, etanercept has also been used in the treatment of psoriatic arthritis and inflammatory bowel disease. While etanercept is effective, certain infect..
|